Sunshine Biopharma, Inc. — Company profile
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 3.33 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 645.57K
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.
Details
| Name | Sunshine Biopharma, Inc. |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 50 |
| Founded | 2006 |
| Ceo | Steve Slilaty |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US8677818820 |
| Cusip | 867781882 |
| Cik | 1402328 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Steve N. Slilaty Ph.D. | Chairman, President and Chief Executive Officer |
| Camille Sebaaly | Chief Financial Officer, Secretary and Director |
| Michel Roy | Chief Commercial Officer |
| Malek Chamoun | Chief Development Officer |
| Robert G. Ferreira | President of Sunshine Bio Investments Inc |
Contact
| Address | 333 Las Olas Way, CU4 Suite 433, Fort Lauderdale, Florida 33301, United States |
| Phone | 954 330 0684 |
| Website | https://sunshinebiopharma.com |